(VIANEWS) – Capital Product Partners L.P. (CPLP), CVS Health (CVS), LeMaitre Vascular (LMAT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Capital Product Partners L.P. (CPLP)
38.3% sales growth and 8.7% return on equity
Capital Product Partners L.P., a shipping company, provides marine transportation services in Greece. Its vessels transports a range of dry cargoes and containerized goods under short-term voyage charters, and medium to long-term time and bareboat charters. As of April 26, 2021, the company owned 17 vessels, including thirteen Neo-Panamax container vessels, three Panamax container vessels, and one Capesize bulk carrier. Capital GP L.L.C. serves as the general partner of the company. The company was incorporated in 2007 and is headquartered in Piraeus, Greece.
Earnings Per Share
As for profitability, Capital Product Partners L.P. has a trailing twelve months EPS of $2.71.
PE Ratio
Capital Product Partners L.P. has a trailing twelve months price to earnings ratio of 6.59. Meaning, the purchaser of the share is investing $6.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.7%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 32.9%, now sitting on 344.97M for the twelve trailing months.
2. CVS Health (CVS)
8.9% sales growth and 11.67% return on equity
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Earnings Per Share
As for profitability, CVS Health has a trailing twelve months EPS of $6.47.
PE Ratio
CVS Health has a trailing twelve months price to earnings ratio of 11.79. Meaning, the purchaser of the share is investing $11.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.67%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.5%, now sitting on 346.6B for the twelve trailing months.
Sales Growth
CVS Health’s sales growth is 7.6% for the present quarter and 8.9% for the next.
Previous days news about CVS Health(CVS)
- Compared to estimates, CVS health (cvs) Q4 earnings: A look at key metrics. According to Zacks on Wednesday, 7 February, "For the quarter ended December 2023, CVS Health (CVS Quick QuoteCVS – Free Report) reported revenue of $93.81 billion, up 11.9% over the same period last year. ", "Here is how CVS Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
- CVS health (cvs) Q4 earnings top estimates, 2024 EPS view down. According to Zacks on Wednesday, 7 February, "During the reported quarter, CVS Health introduced CVS Caremark TrueCost, a model innovation that offers client pricing reflecting the true net cost of prescription drugs, with visibility into administrative fees.", "CVS Health Corporation price-consensus-eps-surprise-chart | CVS Health Corporation Quote"
3. LeMaitre Vascular (LMAT)
7.1% sales growth and 9.92% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access in patients with or without a previously-failed synthetic graft; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, LeMaitre Vascular has a trailing twelve months EPS of $1.22.
PE Ratio
LeMaitre Vascular has a trailing twelve months price to earnings ratio of 47.74. Meaning, the purchaser of the share is investing $47.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.92%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 14, 2023, the estimated forward annual dividend rate is 0.56 and the estimated forward annual dividend yield is 0.96%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
LeMaitre Vascular’s EBITDA is 98.45.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 44% and 29.6%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.5%, now sitting on 185.56M for the twelve trailing months.
4. Gartner (IT)
6.5% sales growth and 370.99% return on equity
Gartner, Inc. operates as a research and advisory company in the United States, Canada, Europe, the Middle East, Africa, and internationally. It operates through three segments: Research, Conferences, and Consulting. The Research segment delivers its research primarily through a subscription service that include on-demand access to published research content, data and benchmarks, and direct access to a network of research experts. The Conferences segment offers business professionals in an organization the opportunity to learn, share, and network. The Consulting segment offers market research, custom analysis, and on-the-ground support services. This segment also offers actionable solutions for IT-related priorities, including IT cost optimization, digital transformation, and IT sourcing optimization. Gartner, Inc. was founded in 1979 and is headquartered in Stamford, Connecticut.
Earnings Per Share
As for profitability, Gartner has a trailing twelve months EPS of $11.63.
PE Ratio
Gartner has a trailing twelve months price to earnings ratio of 39.87. Meaning, the purchaser of the share is investing $39.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 370.99%.
Sales Growth
Gartner’s sales growth is 5.4% for the ongoing quarter and 6.5% for the next.
Volume
Today’s last reported volume for Gartner is 205143 which is 55.49% below its average volume of 460909.
Yearly Top and Bottom Value
Gartner’s stock is valued at $463.71 at 15:22 EST, below its 52-week high of $471.76 and way above its 52-week low of $292.60.
5. CSG Systems International (CSGS)
5.7% sales growth and 24.38% return on equity
CSG Systems International, Inc. provides revenue management, customer experience, and payment solutions primarily to the communications industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers Advanced Convergent Platform, a private cloud-based platform; related customer communications management solutions, including field force automation, analytics, electronic bill presentment, ACH, etc. for processing voice, SMS/text, print, and e-mail messages; and cloud-based integrated suite of solutions for range of industries. The company also provides managed services; and professional services to implement, configure, and maintain its solutions, as well as licenses various solutions, such as mediation, partner management, rating, and charging. It serves financial services, healthcare, media and entertainment companies, and government markets. The company was incorporated in 1994 and is headquartered in Greenwood Village, Colorado.
Earnings Per Share
As for profitability, CSG Systems International has a trailing twelve months EPS of $2.4.
PE Ratio
CSG Systems International has a trailing twelve months price to earnings ratio of 21.73. Meaning, the purchaser of the share is investing $21.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.38%.
Yearly Top and Bottom Value
CSG Systems International’s stock is valued at $52.15 at 15:22 EST, way under its 52-week high of $69.35 and way above its 52-week low of $46.19.
